tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (JP:4536)
:4536
Japanese Market

Santen Pharmaceutical Co (4536) Ratios

Compare
0 Followers

Santen Pharmaceutical Co Ratios

JP:4536's free cash flow for Q4 2024 was ¥0.57. For the 2024 fiscal year, JP:4536's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.38 2.54 2.38 2.39 2.63
Quick Ratio
1.94 2.08 1.94 2.01 2.10
Cash Ratio
0.65 1.02 0.65 0.87 0.80
Solvency Ratio
0.02 0.34 0.02 0.36 0.26
Operating Cash Flow Ratio
0.42 0.78 0.42 0.48 0.49
Short-Term Operating Cash Flow Coverage
0.00 1.35K 0.00 0.00 0.00
Net Current Asset Value
¥ 85.44B¥ 105.81B¥ 85.44B¥ 106.29B¥ 110.93B
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.08 0.09 0.07 0.03
Debt-to-Equity Ratio
0.12 0.11 0.12 0.10 0.03
Debt-to-Capital Ratio
0.11 0.10 0.11 0.09 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.08 0.00 0.00 0.00
Financial Leverage Ratio
1.43 1.42 1.43 1.36 1.31
Debt Service Coverage Ratio
3.41 19.60 3.41 38.13 16.29
Interest Coverage Ratio
-2.06 14.47 -2.06 29.68 8.68
Debt to Market Cap
0.00 0.05 0.00 0.00 0.00
Interest Debt Per Share
97.33 103.09 97.33 85.40 29.12
Net Debt to EBITDA
-1.52 -1.05 -1.52 -0.92 -1.76
Profitability Margins
Gross Profit Margin
59.52%54.27%59.52%58.81%60.65%
EBIT Margin
-1.54%10.78%-1.54%13.83%4.84%
EBITDA Margin
5.12%18.70%5.12%20.48%12.02%
Operating Profit Margin
-1.11%12.76%-1.11%13.48%5.17%
Pretax Profit Margin
-2.08%9.89%-2.08%13.38%4.98%
Net Profit Margin
-5.36%8.82%-5.36%10.22%2.74%
Continuous Operations Profit Margin
-5.37%8.84%-5.37%10.21%3.66%
Net Income Per EBT
257.77%89.18%257.77%76.42%55.00%
EBT Per EBIT
187.67%77.51%187.67%99.25%96.14%
Return on Assets (ROA)
-3.55%6.11%-3.55%5.92%1.70%
Return on Equity (ROE)
-5.08%8.70%-5.08%8.06%2.22%
Return on Capital Employed (ROCE)
-0.93%11.24%-0.93%9.85%3.99%
Return on Invested Capital (ROIC)
-2.41%9.97%-2.41%7.52%2.13%
Return on Tangible Assets
-4.60%7.57%-4.60%8.25%2.36%
Earnings Yield
-3.41%5.11%-3.41%5.55%1.12%
Efficiency Ratios
Receivables Turnover
2.60 3.34 2.60 2.67 2.60
Payables Turnover
4.47 5.74 4.47 4.49 4.05
Inventory Turnover
2.87 3.20 2.87 2.95 2.36
Fixed Asset Turnover
4.22 4.22 4.22 4.73 6.32
Asset Turnover
0.66 0.69 0.66 0.58 0.62
Working Capital Turnover Ratio
2.17 2.26 2.17 2.04 1.79
Cash Conversion Cycle
185.65 160.04 185.65 178.86 204.72
Days of Sales Outstanding
140.18 109.44 140.18 136.52 140.37
Days of Inventory Outstanding
127.17 114.15 127.17 123.61 154.50
Days of Payables Outstanding
81.70 63.55 81.70 81.27 90.15
Operating Cycle
267.35 223.59 267.35 260.14 294.87
Cash Flow Ratios
Operating Cash Flow Per Share
95.88 198.01 95.88 115.17 97.15
Free Cash Flow Per Share
32.42 168.88 32.42 25.52 37.56
CapEx Per Share
63.47 29.13 63.47 89.65 59.59
Free Cash Flow to Operating Cash Flow
0.34 0.85 0.34 0.22 0.39
Dividend Paid and CapEx Coverage Ratio
1.00 3.22 1.00 0.96 1.11
Capital Expenditure Coverage Ratio
1.51 6.80 1.51 1.28 1.63
Operating Cash Flow Coverage Ratio
1.03 2.07 1.03 1.40 3.82
Operating Cash Flow to Sales Ratio
0.13 0.24 0.13 0.17 0.16
Free Cash Flow Yield
2.87%11.89%2.87%2.08%2.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-29.29 19.55 -29.29 18.02 89.07
Price-to-Sales (P/S) Ratio
1.57 1.73 1.57 1.84 2.44
Price-to-Book (P/B) Ratio
1.49 1.70 1.49 1.45 1.98
Price-to-Free Cash Flow (P/FCF) Ratio
34.86 8.41 34.86 48.08 40.55
Price-to-Operating Cash Flow Ratio
11.79 7.17 11.79 10.65 15.68
Price-to-Earnings Growth (PEG) Ratio
0.19 -0.07 0.19 0.06 -1.25
Price-to-Fair Value
1.49 1.70 1.49 1.45 1.98
Enterprise Value Multiple
29.10 8.18 29.10 8.08 18.52
Enterprise Value
416.09B 461.56B 416.09B 440.44B 555.63B
EV to EBITDA
29.10 8.18 29.10 8.08 18.52
EV to Sales
1.49 1.53 1.49 1.65 2.23
EV to Free Cash Flow
33.13 7.45 33.13 43.17 37.03
EV to Operating Cash Flow
11.20 6.35 11.20 9.57 14.32
Tangible Book Value Per Share
489.40 603.86 489.40 482.55 418.86
Shareholders’ Equity Per Share
758.81 834.19 758.81 844.19 770.01
Tax and Other Ratios
Effective Tax Rate
-1.58 0.11 -1.58 0.24 0.46
Revenue Per Share
720.24 823.04 720.24 666.02 624.86
Net Income Per Share
-38.58 72.62 -38.58 68.08 17.10
Tax Burden
2.58 0.89 2.58 0.76 0.55
Interest Burden
1.35 0.92 1.35 0.97 1.03
Research & Development to Revenue
0.10 0.08 0.10 0.10 0.10
SG&A to Revenue
0.34 0.30 0.34 0.32 0.32
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-2.48 2.73 -2.48 1.69 5.84
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis